Works matching IS 21938210 AND DT 2024 AND VI 14 AND IP 1
Results: 19
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 83, doi. 10.1007/s13555-023-01085-w
- By:
- Publication type:
- Article
Drug- or Vaccine-Induced/Aggravated Psoriatic Arthritis: A Systematic Review.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 59, doi. 10.1007/s13555-023-01082-z
- By:
- Publication type:
- Article
Cutaneous Components Leading to Pruritus, Pain, and Neurosensitivity in Atopic Dermatitis: A Narrative Review.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 45, doi. 10.1007/s13555-023-01081-0
- By:
- Publication type:
- Article
The Burden of Air Pollution on Skin Health: a Brief Report and Call to Action.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 251, doi. 10.1007/s13555-023-01080-1
- By:
- Publication type:
- Article
The Microbiome and Acne: Perspectives for Treatment.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 31, doi. 10.1007/s13555-023-01079-8
- By:
- Publication type:
- Article
Evaluation of a Novel Microfocused Ultrasound with Three‐Dimensional Digital Imaging for Facial Tightening: A Prospective, Randomized, Controlled Trial.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 233, doi. 10.1007/s13555-023-01078-9
- By:
- Publication type:
- Article
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 15, doi. 10.1007/s13555-023-01074-z
- By:
- Publication type:
- Article
Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 5, doi. 10.1007/s13555-023-01073-0
- By:
- Publication type:
- Article
Biologics in Prevention of Psoriasis to Psoriatic Arthritis Transition: The Need of Prospective Analyses and Stratification According to Time-Related Risk Factors.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 213, doi. 10.1007/s13555-023-01071-2
- By:
- Publication type:
- Article
Natural History of Keloids: A Sociodemographic Analysis Using Structured and Unstructured Data.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 131, doi. 10.1007/s13555-023-01070-3
- By:
- Publication type:
- Article
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 201, doi. 10.1007/s13555-023-01068-x
- By:
- Publication type:
- Article
Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 151, doi. 10.1007/s13555-023-01067-y
- By:
- Publication type:
- Article
Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 115, doi. 10.1007/s13555-023-01066-z
- By:
- Publication type:
- Article
Redefining Disease Severity with Special Area Involvement and Reflecting on Treatment Patterns in a Real-World Psoriasis Population.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 187, doi. 10.1007/s13555-023-01065-0
- By:
- Publication type:
- Article
Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 99, doi. 10.1007/s13555-023-01064-1
- By:
- Publication type:
- Article
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 261, doi. 10.1007/s13555-023-01061-4
- By:
- Publication type:
- Article
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 169, doi. 10.1007/s13555-023-01058-z
- By:
- Publication type:
- Article